The Journal of Nuclear Medicine (JNM)

Editor in Chief: Johannes Czernin, MD
University of California–Los Angeles

Founded in 1960, The Journal of Nuclear Medicine (JNM) is the world’s leading nuclear medicine, molecular imaging and theranostics journal, accessed 15 million times each year by practitioners around the globe, providing them with the information they need to advance this rapidly expanding field. JNM includes hot topics and state-of-the-art reports as well as clinical and basic science research in oncology, theranostics, neurology, cardiology, and radiation biology.

According to the 2022 Journal Citation Reports™ (released in June 2023), JNM ranks sixth in impact among 203 medical imaging journals worldwide.

  • Impact factor – 9.3
  • Five-year impact factor – 9.0
  • Immediacy index – 4.6
  • Total citations – 31,896
  • Eigenfactor Score – 0.02649
  • Article Influence Score – 2.257

JNM offers:

  • Continuing education articles approved for 2.0 AMA/PRA category 1 credit and SAM credit
  • VOICE-approved articles for continuing education credit
  • More than 60 years of archived content—free with subscription
  • Online access and search tools—free with subscription

Information for Authors

Visit the official JNM website.


Follow us on Twitter, Facebook, and LinkedIn.